Global Fund approves $2.4B for ninth round grants

NewsGuard 100/100 Score

During its recent board meeting in Addis Ababa, Ethiopia, the Global Fund to Fight AIDS, Tuberculosis and Malaria approved $2.4 billion for the three diseases, PlusNews reports. The money is for the fund's "ninth round of grants, bringing the total amount of approved funding since its inception in 2001 to $18.4 billion," according to the publication.

Tedros Adhanom Ghebreyesus, the Ethiopian health minister and chair of the Global Fund board, said, "These grants enable countries around the world to address some of the main problems they are struggling with every day" (11/13).

Global Fund Executive Director Michel Kazatchkine said, "We are seeing a tremendous demand for funding. We may not be able to continue approving such amounts of financing unless donor countries scale up their funding even further," Reuters reports. According to the news service, in July, the Global Fund said "it was facing a budget shortfall of about $3 billion as rich countries cut foreign aid in response to the global downturn" (Malone, 11/12).

According to a Global Fund press release, "The Global Fund Board also approved a new grant architecture to simplify management of Global Fund financing" (11/12).

The China Post writes that programs financed by the Global Fund "have put 2.3 million people on treatment for HIV/AIDS, while another 5.4 million people were treated for TB and 88 million treated nets were distributed to prevent the spread of malaria" (11/13).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis